FDA Class II Drug Recall: Agebox iKids-Growth Capsules
Summary
The FDA has initiated a Class II recall for Agebox iKids-Growth (Day Formula) capsules due to the presence of undeclared ibutamoren. The product was distributed nationwide in the U.S. through Agebox.com and Amazon.com.
What changed
The Food and Drug Administration (FDA) has issued a Class II recall for Agebox iKids-Growth (Day Formula) capsules (60-count bottles, UPC 8 50065 59701 0). The recall is due to the product being marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), specifically because it contains undeclared ibutamoren. The product was manufactured exclusively for AGEBOX Inc. and distributed nationwide via Agebox.com and Amazon.com.
This action requires Agebox Inc. and its distributors to immediately cease distribution and notify retailers and consumers about the recall. While classified as Class II, indicating that use or exposure may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote, affected parties should take prompt action to remove the product from shelves and inform consumers. The FDA is monitoring the recall process, which is ongoing.
What to do next
- Remove Agebox iKids-Growth capsules from inventory and distribution channels.
- Notify all retailers and consumers about the recall and the presence of undeclared ibutamoren.
- Comply with FDA reporting requirements for the recall process.
Source document (simplified)
Agebox
Drug Recalls (Class II)
← All Drug Recalls (Class II) Class II D-0344-2026 · 20260304 · Ongoing
Product
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 8 50065 59701 0
Reason for Recall
Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Distribution
The product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Drug Recalls Class II publishes new changes.